Keytruda

Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster
Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster
Motley Fool
Pfizer
Inlyta
kidney cancer
Merck
Keytruda
Flag link:
Merck, Pfizer drug combo extends kidney cancer survival -study
Merck, Pfizer drug combo extends kidney cancer survival -study
Yahoo/Reuters
Merck
Pfizer
kidney cancer
Keytruda
Inlyta
Sutent
Flag link:
Keytruda-Inlyta combo under Priority Review for first-line RCC
Keytruda-Inlyta combo under Priority Review for first-line RCC
BioCentury
Merck
Keytruda
Inlyta
renal cell carcinoma
FDA
priority review
Flag link:
Merck plans trio of Phase 3 Keytruda studies in prostate cancer
Merck plans trio of Phase 3 Keytruda studies in prostate cancer
BioPharma Dive
Merck
Keytruda
prostate cancer
clinical trials
Flag link:
Asco-GU – Bristol’s renal cancer lead looks to be short-lived
Asco-GU – Bristol’s renal cancer lead looks to be short-lived
EP Vantage
renal cell carcinoma
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
clinical trials
Sutent
Flag link:
FDA promises speedy review on moving Merck's Keytruda up as first-line head and neck cancer therapy
FDA promises speedy review on moving Merck's Keytruda up as first-line head and neck cancer therapy
Endpoints
Merck
Keytruda
FDA
head and neck cancer
priority review
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Motif Biosciences
Iclaprim
Merck
Keytruda
melanoma
JNJ
esketamine
ASCO
Pfizer
Veru. earnings
Aveo Pharmaceuticals
Calithera Biosciences
Flag link:
Forget Bristol-Myers: Regeneron takes on Merck for the heavyweight title in non-small cell lung cancer
Forget Bristol-Myers: Regeneron takes on Merck for the heavyweight title in non-small cell lung cancer
Endpoints
Regeneron
Merck
Bristol-Myers Squibb
PD-1/L1 therapy
Libtayo
Keytruda
Opdivo
non-small cell lung cancer
Flag link:
Mark Your Calendar For These February PDUFA Dates
Mark Your Calendar For These February PDUFA Dates
Yahoo/Benzinga
FDA
DWP-450
Evolus
MOTIF BIO PLC/S ADR
Iclaprim
Bausch Health
Duobrii
Merck
Keytruda
Incyte
Novartis
ruxolitinib
Novo Nordisk
N8-GP
Flag link:
Merck analysts to CEO: What’s so great about your pipeline beyond Keytruda?
Merck analysts to CEO: What’s so great about your pipeline beyond Keytruda?
Fierce Pharma
Merck
Keytruda
vaccines
Flag link:
Merck's Keytruda slashes death risk by 31% in esophageal cancer victory
Merck's Keytruda slashes death risk by 31% in esophageal cancer victory
Fierce Pharma
Merck
Keytruda
esophageal cancer
Flag link:
Merck's Keytruda faces delay in first-line approval decision
Merck's Keytruda faces delay in first-line approval decision
Biopharma Dive
FDA
Keytruda
Merck
metastatic non-small cell lung cancer
Flag link:
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Fierce Pharma
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
Flag link:
Merck bags adjuvant okay for Keytruda in melanoma
Merck bags adjuvant okay for Keytruda in melanoma
Pharmaforum
Merck
Europe
Keytruda
melanoma
Flag link:
Merck increased list prices on Keytruda, Gardasil in November
Merck increased list prices on Keytruda, Gardasil in November
Biopharma Dive
Merck
drug pricing
Keytruda
Gardasil
Flag link:
One more shot at slowing Keytruda’s first-line lung cancer domination
One more shot at slowing Keytruda’s first-line lung cancer domination
EP Vantage
Keytruda
Merck
Roche
Tecentriq
Avastin
lung cancer
Flag link:
Merck's Keytruda picks up first-in-class survival win in esophageal cancer
Merck's Keytruda picks up first-in-class survival win in esophageal cancer
Fierce Pharma
Merck
Keytruda
esophageal cancer
Flag link:
GSK pancreatic cancer drug heads to phase 1 combo with Merck's Keytruda after positive mouse trial
GSK pancreatic cancer drug heads to phase 1 combo with Merck's Keytruda after positive mouse trial
Fierce Biotech
GSK
GSK095
Merck
Keytruda
pancreatic cancer
Flag link:
Merck gets FDA okay for Keytruda as liver cancer therapy
Merck gets FDA okay for Keytruda as liver cancer therapy
Pharmaforum
Merck
Keytruda
FDA
hepatocellular carcinoma
liver cancer
Flag link:
OncoSec’s defense of weak preliminary Tavo data for PD-1 resistant melanoma can’t stop a rout
OncoSec’s defense of weak preliminary Tavo data for PD-1 resistant melanoma can’t stop a rout
Endpoints
OncoSec
Merck
Keytruda
Tavo
melanoma
Flag link:

Pages